Nuclein
Austin, Texas, United States · Biotechnology · 69 employees
Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR Sy
Funding history
- Funding Round — $19.1M — Apr 2026
- Funding Round — $9.4M — Feb 2026
- Funding Round — $14.9M — Dec 2025
- Funding Round — $9.8M — Oct 2025
- Series seed — $750K — Feb 2025
Recent signals
- Apr 27, 2026: Raised $19.1M
- Feb 05, 2026: Raised $9.4M
- Dec 17, 2025: Raised $14.9M
- Oct 14, 2025: Raised $9.8M
- Feb 03, 2025: Raised $750K in Series seed
- Aug 05, 2024: Raised $8.8M
- Jan 19, 2021: Raised Undisclosed
- Sep 10, 2019: Raised $9.4M
See plans & pricing → Track Nuclein’s funding, hiring, and signals — with verified contacts — on Fundz.